KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Deferred Taxes: 2009-2025

Historic Deferred Taxes for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to -$127.0 million.

  • Thermo Fisher Scientific's Deferred Taxes rose 68.25% to -$127.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 540.24%. This contributed to the annual value of $1.2 billion for FY2024, which is 7.00% down from last year.
  • Per Thermo Fisher Scientific's latest filing, its Deferred Taxes stood at -$127.0 million for Q3 2025, which was up 85.57% from -$880.0 million recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Deferred Taxes ranged from a high of $2.2 billion in Q4 2024 and a low of -$880.0 million during Q2 2025.
  • In the last 3 years, Thermo Fisher Scientific's Deferred Taxes had a median value of $182.0 million in 2023 and averaged $161.9 million.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Deferred Taxes skyrocketed by 1,512.50% in 2022, and later tumbled by 572.53% in 2024.
  • Thermo Fisher Scientific's Deferred Taxes (Quarterly) stood at $192.0 million in 2021, then slumped by 30.73% to $133.0 million in 2022, then spiked by 403.01% to $669.0 million in 2023, then skyrocketed by 231.24% to $2.2 billion in 2024, then surged by 68.25% to -$127.0 million in 2025.
  • Its last three reported values are -$127.0 million in Q3 2025, -$880.0 million for Q2 2025, and $279.0 million during Q1 2025.